With the above promising in vitro results, we finally investigated whether this RNA interference (RNAi) nanoplatform could effectively deliver siRNA into tumor tissues to silence SERPINB3 expression and reverse HPV‐negative PDX chemoresistance. Here, SERPINB3 is linked to neoplasm.